Healthy high growth potential

Results

1546

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1546 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
ADMR
Rp1,680.000%66.3%Rp68.7tRp2,340.8313.226.8%2.8%Materials
NORTHERN
RM 0.690%-7.4%RM 271.0mRM 1.0017.739.5%n/aCapital Goods
6223
NT$5,565.00-4.1%343.4%NT$545.3bNT$8,581.54119.161.5%0.4%Semiconductors
GOLDR
NOK 7.945.6%n/aNOK 455.2mn/a20.986.0%n/aMaterials
FWRY
ج.م19.05-0.4%38.8%ج.م64.9bج.م22.4522.527.9%n/aDiversified Financials
WAYS
SEK 38.10-2.3%-4.5%SEK 334.1mSEK 58.00202.778.5%0%Tech
TMGH
ج.م98.001.6%78.9%ج.م201.9bج.م141.9013.135.9%0.3%Real Estate Management and Development
AXSM
US$205.40-5.0%76.6%US$10.9bUS$285.4213.961.2%n/aPharmaceuticals & Biotech
CDR
zł257.20-0.2%-0.7%zł25.7bzł236.0549.839.6%0.4%Media
AGP
€7.13-0.7%-12.4%€130.0m€8.5726.239.1%n/aCapital Goods
AAZ
UK£4.101.2%156.3%UK£468.8mUK£5.6836.125.9%0.7%Materials
LPK
€12.65-15.9%59.1%€309.4m€22.753.1116.6%0%Tech
SAUD3
R$13.930.8%7.2%R$40.7bR$17.6938.631.9%5.8%Healthcare
TGTX
US$56.0113.7%96.3%US$7.7bUS$69.7118.021.3%n/aPharmaceuticals & Biotech
MDGL
US$511.97-2.5%24.2%US$11.9bUS$678.069.263.7%n/aPharmaceuticals & Biotech
NVDA
US$208.48-7.3%15.9%US$5.2tUS$304.7331.622.9%0.5%Semiconductors
SPCX
US$135.00-7.7%n/aUS$1.9tUS$216.3379.556.5%n/aTelecom
MOD
US$188.37-13.1%36.4%US$10.5bUS$310.2969.451.3%n/aCapital Goods
RHM
€1,125.20-7.3%-31.8%€52.6b€1,679.3843.430.5%1.0%Capital Goods
LITE
US$830.17-14.3%572.6%US$77.7bUS$1,148.3024.7104.4%n/aTech
CRDO
US$222.61-21.3%92.9%US$43.0bUS$283.2387.927.7%n/aSemiconductors
300432
CN¥15.70-7.4%-0.1%CN¥27.4bCN¥34.4053.060.7%0.6%Automobiles
002810
CN¥21.451.5%47.9%CN¥7.5bCN¥36.0030.742.5%1.9%Materials
002975
CN¥107.182.2%193.7%CN¥22.7bCN¥130.0095.844.2%0%Tech
Page 1 of 43